Abstract
Purpose
The purpose of this study is to assess the utility of intraorbital injection of triamcinolone acetonide as a primary treatment option for orbital reactive lymphoid hyperplasia (RLH).
Patients and method
Retrospective, single-centre, interventional case series.
Results
Intraorbital injection of triamcinolone acetonide was associated with complete resolution of all symptoms and signs in four cases (80%). This was achieved with a single injection in two cases and with two injections in another two cases. Radiological resolution was confirmed in one case. One case developed bilateral multifocal orbital RLH lesions 1 month after the second injection.
Conclusion
Intraorbital injection of corticosteroid may be a useful treatment option for orbital RLH, and may have a role as a first-line therapy in RLH of the anterior orbit. A significant proportion of patients may require repeat injections to achieve resolution. A larger prospective study is required to validate our findings.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Talaulikar D, Tridgell D, Leong D, Dahlstrom JE, Cherian M, Prosser I et al. Novel therapeutic option for orbital atypical lymphoid hyperplasia. Clin Exper Ophthalmol 2010; 38 (9): 892–894.
Molloy ES, Calabrese LH . Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapies. Arthritis Rheum 2012; 64 (9): 3043–3051.
Skaat A, Rosen N, Rosner M, Schiby G, Simon GJ . Triamcinolone acetonide injection for persistent atypical idiopathic orbital inflammation. Orbit 2009; 28 (6): 401–403.
Leibovitch I, Prabhakaran VC, Davis G, Selva D . Intraorbital injection of triamcinolone acetonide in patients with idiopathic orbital inflammation. Arch Ophthalmol 2007; 125 (12): 1647–1651.
Ahmed TY, Agarwal PK, Roberts F, Diaper CJ . Periocular steroids in conjunctival reactive lymphoid hyperplasia, a new approach? Clin Exper Ophthalmol 2011; 39 (6): 576–577.
Telander DG, Lee TZ, Pambuccian SE, Huang AJ . Subconjunctival corticosteroids for benign lymphoid hyperplasia. Br J Ophthalmol 2005; 89 (6): 770–771.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Andrew, N., Kearney, D. & Selva, D. Intraorbital corticosteroid injection for orbital reactive lymphoid hyperplasia. Eye 27, 561–563 (2013). https://doi.org/10.1038/eye.2012.288
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2012.288
